Redefine disinfection
Missed the BPR deadline for ADBAC/BKC (C12-C16) based products in PT 2?
The July 2025 deadline for submitting the biocidal product dossier for ADBAC (C12-C16) based products in Product Type 2 (PT 2) has passed. If your ADBAC-based disinfectant products dossier haven't been submitted, we're here to help.
In December 2021, the EU Chemicals Agency (ECHA) Biocidal Products Committee (BPC) adopted an opinion for approval of ADBAC (C12-C16) in PT 2 (disinfectants and algaecides not intended for direct application to humans or animals). Based on this BPC opinion, the approval date of ADBAC (C12-C16) for PT 2 biocidal applications was July 2025.
To continue selling your ADBAC/BKC (C12-C16) based products in the EU, a BPR product dossier should have been submitted by the July active substance approval date.
What happens when your dossier isn't submitted on time?
According to the Biocidal Products Regulation (BPR), the consequences are clear:
• Loss of Market Availability: If a product authorization application is not submitted by the designated deadline, the biocidal product can no longer be made available on the market. This takes effect 180 days after the deadline.
• Disposal and use of existing stocks of the biocidal product may continue up to 365 days after the approval of the active substance.
Conceptual image of decision-making, symbolizing choices in hospital disinfection strategies and hygiene solutionsHere's where Arxada steps in — and why it's a game-changer for you:
At Arxada, we understand the complexities of BPR regulations and the challenges you face. That's why we offer solutions that can simplify your time to market.
Explore our range of solutions:
We provide ready-to-use NUGEN® disinfectant formulations and Bardac®2080 active substances based upon DDAC (C8-C10).
All NUGEN® formulations are ready for immediate market introduction in EU Member States – under your own brand!
We ensure that all our products meet national notification requirements and adhere to rigorous safety and efficacy standards.
Key benefits:
• Our formulated DDAC C8-C10 based solutions are available for a quick adoption.
• Streamline your processes with Arxada's formulations, supported by wide data set for immediate implementation/adoption.
• Boost performance: DDAC (C8-C10) offers superior efficacy at lower concentrations compared to ADBAC (C12-C16).
Customers adopting NUGEN® disinfectants, disinfectant cleaners and disinfectant soaps will be supported through their notification process. Arxada’s support will vary depending on the country of notification/registration and may include e.g. ‘How To’ guidance documents (on how to comply with national requirements in relevant European countries under the Transitional Arrangements of the BPR), Letters of Access (LoA) and Letters of Supply (LoS).
Future-Proof Your Disinfection Business: Webinar replay now available
We had a great turnout for our webinar on disinfection regulations. For those who misse it or want ro revisit the key takeways, the recording is now available.
For the most up to date national notification status or for further information on how Arxada may be able to support you with a notification/registration in your country of interest, please contact your Arxada sales representative or send an email: hygiene@arxada.com
By choosing Arxada, you can focus on your core business while we take care of the regulatory complexities. Together, we can ensure a sustainable and successful future for your disinfectant products.
Connect with an Arxada representative to discuss your disinfection requirements.
Featured content
Get in touch
For more information or to stay up-to-date with our news, please contact us or sign up to our e-Newsletter.